These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549 [TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810 [TBL] [Abstract][Full Text] [Related]
28. Successful Management of a Patient With Possible Mast Cell Activation Syndrome Undergoing Pulmonary Embolectomy: A Case Report. Richter EW; Hsu KL; Moll V A A Case Rep; 2017 May; 8(9):232-234. PubMed ID: 28181942 [TBL] [Abstract][Full Text] [Related]
29. [Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital]. Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G Lakartidningen; 2008 Nov 12-18; 105(46):3341-4, 3346-7. PubMed ID: 19062626 [No Abstract] [Full Text] [Related]
30. [Mastocytosis--a review illustrated by two case reports]. Dalgaard J; Ritland S; Brinch L; Ikonomou IM Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1312-5. PubMed ID: 10868093 [TBL] [Abstract][Full Text] [Related]
37. Classification and response criteria in mast cell disorders: time to revise? Valent P; Horny HP Int Arch Allergy Immunol; 2011; 155(3):306-8. PubMed ID: 21293151 [No Abstract] [Full Text] [Related]